Feng Wang
Publications :
37
Aldex :
10
H-index :
5
Citations :
406
Feng Wang
Publications :
37
Aldex :
10
H-index :
5
Citations :
406
Single-Band Upconversion Emission in Lanthanide-Doped KMnF3 Nanocrystals
Juan Wang, Xiaogang Liu et 4 al.
Sep 14, 2011 in Angewandte Chemie
Genakumab Alone and in Combination With Tislelizumab in Patients With Advanced Malignant Solid Tumors
Tao Zhang et 4 al.
Jun 16, 2022 in ClinicalTrials.gov
This is a phase I, multicenter, open-label dose escalation and expansion study to evaluate genakumab alone and in combination with tislelizumab in adult patients with advanced solid malignancies.
The Efficacy and Safety of Intracranial Stent (Tonbridge) in Endovascular Treatment of Intracranial Atherosclerotic Stenosis
Conghui Li, Chun Fang et 12 al.
Oct 20, 2022 in ClinicalTrials.gov
The purpose of this study is to verify the efficacy and safety of the Intracranial Stent (Tonbridge) in endovascular treatment of intracranial atherosclerotic stenosis.
A Trail of Drug-coated Balloon Treating Below The Knee Arterial Diseases
Shengyun Wan, Minyi Yin et 19 al.
Jun 6, 2022 in ClinicalTrials.gov
This is a prospective, multicenter, randomized controlled trail using drug-coated balloon to treat below the knee arterial stenosis or occlusion.
Clinical Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients
Feng Wang, Wenyu Wu
Sep 13, 2021 in ClinicalTrials.gov
The overall objective of this study is to evaluate the overall pattern of [18F]APN-1607 uptake in subjects with AD dementia
Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma
Feng Wang
Dec 4, 2018 in ClinicalTrials.gov
The purpose of this study is to observe and evaluate the efficacy and safety of anti-PD-1 antibody SHR-1210 combined with nimotuzumab as second-line therapy in patients with advanced cancerous esophageal squamous cell carcinoma.
Toripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed Chemotherapy
Rui-Hua Xu, Rui-Hua Xu et 2 al.
Jan 17, 2019 in ClinicalTrials.gov
To evaluate the anti-tumor activity, safety and tolerance of toripalimab as monotherapy for patients with small cell esophageal cancer (SCCE), and to explore the potential biomarkers for this treatment.
Camrelizumab(SHR-1210) Combined With Apatinib in the Treatment of Advanced Metastatic Colorectal Cancer
Rui-Hua Xu et 3 al.
Apr 9, 2019 in ClinicalTrials.gov
The incidence and mortality of colorectal cancer in China's cancer disease spectrum is on the rise, and it is a common malignant tumor that harms the health of Chinese residents. This study was a one-arm, single-center, open clinical study. A total of 50 patients were enrolled in the study.
The Phase II Trial of SHR-1210 Combined With Preoperative Chemotherapy or Apatinib for Locally Advanced ESCC
Feng Wang
Apr 14, 2019 in ClinicalTrials.gov
The purpose of this study is to observe and evaluate the efficacy and safety of SHR-1210 combined with preoperative chemotherapy or Apatinib for locally advanced esophageal squamous cell carcinoma
Decitabine Plus Penpulimab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade
Feng Wang
Feb 7, 2022 in ClinicalTrials.gov
The purpose of this study is to observe and evaluate the efficacy and safety of Decitabine plus Penpulimab as second-line therapy for advanced esophageal squamous cell carcinoma treated with PD-1 blockade